Direct treatment comparison of DAbigatran and RIvaroxaban versus NAdroparin in the prevention of venous thromboembolism after total knee arthroplasty surgery: design of a randomised pilot study (DARINA)

INTRODUCTION: Two novel agents, dabigatran and rivaroxaban, recently gained market authorisation for prevention of venous thromboembolism (VTE) after hip and knee arthroplasty. However, safety data of the new oral anticoagulants with a long-term use of 42 days are not available for total knee arthro...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: van Veen, Lucia, van Raay, Jos JAM, Gerritsma-Bleeker, Carina L E, Veeger, Nic JGM, van Hulst, Marinus
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2013
Pynciau:
Medical Management
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3563127/
https://ncbi.nlm.nih.gov/pubmed/23355673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2012-002218
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg